1. The People’s Choice: Premeasured Single Dosage Forms
    David Kudla, General Manager for North America and Rao Tatapudy, R.Ph., Ph.D., Executive Director, Research & Development for Unither Pharmaceuticals, discuss unit dosing and patient compliance.
  2. A Culture of Innovation in Southeast England

    Sarah Haywood, the CEO for MedCity, explains the organization.

  3. LabCorp Makes Another Acquisition

    LabCorp purchases UK-based contract research organization Chiltern for $1.2 billion.

  4. Genetic Analysis of Solid Tumors Provides Insight on How They Spread

    New gene sequencing technique developed by University of Michigan researchers reveals that metastasized tumors have many more mutations.

  5. Avara on the Road to BIO: Taking Direction From Industry Veterans
    Bill Pasek, Executive Vice President & Chief Commercial Officer for Avara Pharmaceutical Services explains honoring commitments.
  6. Serialization: The First Steps In Sales Unit Traceability and Data Management
    Michael Kinsella, Projects Director Serialization & Packaging, Supply Chain at Servier CDMO explores the impact of serialization. 
  7. Academic-Industry Partnership Receives Funds to Develop Ebola Vaccine

    Integrated BioTherapeutics and The Scripps Research Institute awarded $6.6 million to develop a vaccine that protects against all ebola viruses.

  8. Study Projects an $18 billion Neuroprosthetics Market by 2028

    Vision and hearing both have a stake in the coming wave of innovation.

  9. Nice Insight Overview: The Key to Pharma’s Next Generation Success

    Evolving markets are prompting drug owners and developers to pursue new business models in the post-blockbuster era.

  10. Process Optimization: Innovation's Role

    Process optimization is a key service for the drug development industry that supports innovation and efficiency.

The Road To BIO: An Epic Jouney
View All
The Road to BIO was a 12-day cross-country journey toward the 2017 BIO International Convention in San Diego. Follow Our Journey
Pharma's Almanac TV
View All Video

The Advantage of Having a Drug Development Company Behind Manufacturing

Stephen Worsley, Vice President, Business Development, Peregrine Pharmaceuticals & Avid Bioservices, Inc. 

Emphasis on Aggressive Cancer Cells

Richard Godfrey, CEO, BerGenBio ASA

Finding the Sweet Spot With Biosimilars and mAbs

Federico Pollano, Director, Polpharma Biologics

Inside Out: Targeting Proteins on Cancer Cells

Mahesh Narayanan, President & CEO, PepVax, Inc. 


Quadruple Myeloma Combination Treatment Study Begins

Aug 17, 2017 4:59:17 PM PAO-M08-17-NI-027

An Existing Diabetes Drug Could Help Patients with Parkinson’s Disease

Aug 17, 2017 4:13:04 PM PAO-M08-17-NI-025

FDA Makes Waves with Generic Approvals

Aug 17, 2017 4:07:38 PM PAO-M08-17-NI-024

Mallinckrodt Acquires InfaCare Pharmaceutical Corporation for $425 Million

Aug 17, 2017 3:54:12 PM PAO-M08-17-NI-023

Study Projects an $18 Billion Neuroprosthetics Market by 2028

Aug 15, 2017 1:09:01 PM PAO-M08-17-NI-022

Academic-Industry Partnership Receives Funds to Develop Ebola Vaccine

Aug 15, 2017 12:14:38 PM PAO-M08-17-NI-021

Genetic Analysis of Solid Tumors Provides Insight on How They Spread

Aug 15, 2017 11:57:35 AM PAO-M08-17-NI-020

LabCorp Makes Another Acquisition

Aug 15, 2017 11:51:43 AM PAO-M08-17-NI-019

Kite Submits Investigational New Drug Application for KITE-585

Aug 11, 2017 3:28:25 PM PAO-M08-17-NI-018

Brains On-Line Acquired by Charles River Laboratories for $21 million

Aug 11, 2017 3:25:43 PM PAO-M08-17-NI-017

Cambrex Invests in New Highly Potent API Manufacturing Capacity

Aug 11, 2017 3:22:34 PM PAO-M08-17-NI-016

Personalized Genetic Screening Launches in the UK

Aug 8, 2017 12:20:53 PM PAO-M08-17-NI-014

Collaboration Targets Vaccine Technologies to Wipe out HIV-1 and Hep-B

Aug 8, 2017 11:48:52 AM PAO-M08-17-NI-013

Celgene’s First-Ever Oral Leukemia Treatment Gets FDA Nod

Aug 8, 2017 11:42:18 AM PAO-M08-17-NI-012
Clinical Trials

Novel Pneumonia-Fighter Enters Pivotal Trial

Aug 8, 2017 11:37:29 AM PAO-M08-17-NI-011

Aptuit Acquisition Positions Evotec for Growth, Expansion

Aug 8, 2017 11:31:19 AM PAO-M08-17-NI-010

Harvard Researchers Develop a New Adhesive That Adheres Even to Wet Wounds

Aug 4, 2017 1:41:58 PM PAO-M08-17-NI-009

WuXi Passes Pre-License Inspection for mAb-Based HIV Treatment Production

Aug 4, 2017 1:35:43 PM PAO-M08-17-NI-008
Capacity Expansion

Boehringer Ingelheim Expands Biologics Manufacturing Capacity in California

Aug 4, 2017 1:11:28 PM PAO-M08-17-NI-007

Joint Program Explores Devices to Treat Gastrointestinal Disease

Aug 1, 2017 12:40:00 PM PAO-M08-17-NI-004

Lonza Pharm&Biotech Constructing Manufacturing Complex in Switzerland

Aug 1, 2017 12:35:46 PM PAO-M08-17-NI-003

Horizon Discovery Acquires GE CRISPR Unit for $85 Million

Aug 1, 2017 12:31:27 PM PAO-M08-17-NI-002

Merck and AstraZeneca Team Up to Fight Cancer

Aug 1, 2017 12:26:40 PM PAO-M08-17-NI-001
  • Innovation

Novel Therapy Targets Obesity-Linked Disease

Jul 28, 2017 11:19:10 AM PAO-M07-17-NI-035

Potential Alzheimer’s Drug Targets Identified

Jul 28, 2017 11:13:37 AM PAO-M07-17-NI-034

New Method for Detecting the Zika Virus Developed

Jul 28, 2017 10:04:58 AM PAO-M07-17-NI-033

Chinese Genetics Company Completes Successful IPO

Jul 28, 2017 9:57:11 AM PAO-M07-17-NI-032

Nice Symposium

Bringing the Supply Chain Together to Tackle Development Challenges
The first-ever “Nice Symposium,” hosted by That’s Nice, brought together a diverse range of service and technology providers and their customers.

Trends Trading

From Blobs to Hearts: Understanding the 3D Bioprinting Revolution
Additive manufacturing (AM), commonly referred to as ‘3D printing,’ is a revolutionary technology that seems to bleed across disciplines.

Nice Insight Overview

Biologics: The Driving Force In Pharma

Nigel Walker, That's Nice/Nice Insight
//Fix for text overflow in cards